The Mumbai-based drug maker has introduced the medication after receiving an approval from the US Food and Drug Administration (USFDA), Lupin said in a statement. The company's product is a generic ...

Shares of Lupin rose nearly 4 percent after the pharmaceutical major announced the launch of Mirabegron Extended-Release tablets (25 mg) in the United States, a drug which has over $1 billion in ...

Lupin and Zydus Life have recently introduced Mirabegron Extended-Release Tablets, 25 mg ... estimated annual sales of $1019 Mn for the 25 mg strength alone, and $2.42 Bn for combined strengths ...

AHMEDABAD, India--(BUSINESS WIRE)-- Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”) announces the launch of ...

End-of-Mission press releases include statements of IMF staff teams that convey preliminary findings after a visit to a country. The views expressed in this statement are those of the IMF staff and do ...

dry cough should be treated by taking expectorant medicine and productive cough (with phlegm) should be treated by taking antitussives or mucolytics like Solmux Advance. “Ugaliing magpakonsulta kaagad ...

Richard Teng, Chief Executive Officer of Binance, says the company is working very closely with the Federal Government of Nigeria for the release of Tigran Gambaryan, the company’s Head of Financial ...

The expansion of the market is influenced by industry-specific factors, each of which is thoroughly identified and elaborated upon in the report The Saudi Arabia cough suppressant drugs ... including ...

Controlled coughing engages the chest and stomach muscles to clear mucus in the lungs. Unlike a hacking cough that uses the chest muscles more than the diaphragm, controlled coughing focuses on ...